![](https://porib.com/wp-content/uploads/2021/06/pharmacoeconomics.jpg)
Buti M, Oyagüez I, Lozano V, Casado MA
Cost-effectiveness of first-line oral antiviral therapies for chronic hepatitis B: A systematic review
Pharmacoeconomics. 2013;31(1):63-75
![](https://porib.com/wp-content/uploads/2021/06/pharmacoeconomics.jpg)
Buti M, Casado MA, Fosbrook L, Esteban R
Buti M, Oyagüez I, Lozano V, Casado MA
Buti M, Casado MA, Fosbrook L, Esteban R